CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-05 | Wang Xiaodong Director | Grant or award | +108,992 | 5,568,430 | ||
| 2024-06-05 | Wang Xiaodong Director | Grant or award · Share Option (Right to Buy) | +410,657 | 410,657 | ||
| 2024-06-05 | Sanders Corazon (Corsee) D. Director | Grant or award | +16,341 | 46,241 | ||
| 2024-06-05 | Sanders Corazon (Corsee) D. Director | Grant or award · Share Option (Right to Buy) | +34,151 | 34,151 | ||
| 2024-06-05 | Wang Julia Aijun Chief Financial Officer | Grant or award | +136,240 | 456,326 | ||
| 2024-06-05 | Wang Julia Aijun Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +256,659 | 256,659 | ||
| 2024-06-05 | BAKER BROS. ADVISORS LP Director | Grant or award | +32,682 | 126,095 | ||
| 2024-06-05 | BAKER BROS. ADVISORS LP Director | Grant or award | +32,682 | 126,099 | ||
| 2024-06-05 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +68,302 | 68,302 | ||
| 2024-06-05 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +68,302 | 68,302 | ||
| 2024-06-05 | Yi Qingqing Director | Grant or award | +16,341 | 45,955 | ||
| 2024-06-05 | Yi Qingqing Director | Grant or award · Share Option (Right to Buy) | +34,151 | 34,151 | ||
| 2024-04-11 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −5,008 | $146.09 | $732K | 7,076 |
| 2024-04-11 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −4,265 | $146.82 | $626K | 2,811 |
| 2024-04-11 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −2,811 | $147.74 | $415K | 0 |
| 2024-04-10 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −11,514 | $148.40 | $1.7M | 27,286 |
| 2024-04-10 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −12,501 | $149.15 | $1.9M | 14,785 |
| 2024-04-10 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −2,641 | $149.79 | $396K | 12,144 |
| 2024-04-10 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −60 | $150.85 | $9K | 12,084 |
| 2024-04-09 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −542 | $152.28 | $83K | 49,458 |
Page 40 of 71 · 1,406 trades